In a filing, Regenxbio Inc revealed its Director KARABELAS ARGERIS N unloaded Company’s shares for reported $0.12 million on Sep 03 ’24. In the deal valued at $11.56 per share,10,000 shares were sold. As a result of this transaction, KARABELAS ARGERIS N now holds 11,286 shares worth roughly $0.12 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, KARABELAS ARGERIS N sold 10,100 shares, generating $136,454 in total proceeds. Upon selling the shares at $13.51, the Director now owns 11,286 shares.
Before that, Simpson Curran sold 100 shares. Regenxbio Inc shares valued at $1,500 were divested by the Chief Executive Officer at a price of $15.00 per share. As a result of the transaction, Simpson Curran now holds 170,037 shares, worth roughly $1.78 million.
Goldman initiated its Regenxbio Inc [RGNX] rating to a Buy in a research note published on June 07, 2024; the price target was $38. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. RBC Capital Mkts also remained covering RGNX and has increased its forecast on March 08, 2024 with a “an Outperform” recommendation from previously “Sector perform” rating. Leerink Partners revised its rating on March 06, 2024. It rated RGNX as “an Outperform” which previously was an “a Market perform”.
Price Performance Review of RGNX
On Monday, Regenxbio Inc [NASDAQ:RGNX] saw its stock fall -2.87% to $10.49. Over the last five days, the stock has lost -10.11%. Regenxbio Inc shares have fallen nearly -41.56% since the year began. Nevertheless, the stocks have fallen -40.67% over the past one year. While a 52-week high of $28.80 was reached on 03/05/24, a 52-week low of $10.49 was recorded on 09/30/24. SMA at 50 days reached $12.28, while 200 days put it at $15.38.
Levels Of Support And Resistance For RGNX Stock
The 24-hour chart illustrates a support level at 10.10, which if violated will result in even more drops to 9.72. On the upside, there is a resistance level at 10.91. A further resistance level may holdings at 11.34. The Relative Strength Index (RSI) on the 14-day chart is 34.94, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.52%. Stochastics %K at 8.86% indicates the stock is a buying.
How much short interest is there in Regenxbio Inc?
A steep rise in short interest was recorded in Regenxbio Inc stocks on 2024-09-13, growing by 0.47 million shares to a total of 6.2 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 5.73 million shares. There was a rise of 7.62%, which implies that there is a positive sentiment for the stock.
